These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37160349)

  • 21. Early evidence of flavored tobacco product restrictions in Massachusetts and New York State.
    Schillo B; Seaman EL; Cuccia A; Ali FRM; Cordova J; Mills S; Kreslake J
    Tob Induc Dis; 2023; 21():140. PubMed ID: 37881173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioural intentions in response to a potential menthol cigarette sales ban: a survey examining smokers in Washington, DC public housing.
    Dearfield CT; Horn K; Crandell I; Bernat DH
    BMJ Open; 2022 Jul; 12(7):e059821. PubMed ID: 35831050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing the uptake and use of nicotine replacement therapy and e-cigarettes in pregnant women who smoke: a qualitative evidence synthesis.
    Campbell K; Coleman-Haynes T; Bowker K; Cooper SE; Connelly S; Coleman T
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013629. PubMed ID: 32441810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating a Real World Ban on Menthol Cigarettes: An Interrupted Time-Series Analysis of Sales.
    Chaiton M; Schwartz R; Shuldiner J; Tremblay G; Nugent R
    Nicotine Tob Res; 2020 Apr; 22(4):576-579. PubMed ID: 30887032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the Impact of Strong and Weak California Flavored Tobacco Sales Restriction Policies on the Tobacco Retail Environment.
    Welwean RA; Andersen-Rodgers E; Akintunde A; Zhang X
    Am J Health Promot; 2022 May; 36(4):687-696. PubMed ID: 35105227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The actual and anticipated effects of a menthol cigarette ban: a scoping review.
    Cadham CJ; Sanchez-Romero LM; Fleischer NL; Mistry R; Hirschtick JL; Meza R; Levy DT
    BMC Public Health; 2020 Jul; 20(1):1055. PubMed ID: 32641026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotine replacement therapy for smoking cessation.
    Silagy C; Mant D; Fowler G; Lancaster T
    Cochrane Database Syst Rev; 2000; (3):CD000146. PubMed ID: 10908462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Menthol e-cigarette sales rise following 2020 FDA guidance.
    Diaz MC; Donovan EM; Schillo BA; Vallone D
    Tob Control; 2021 Nov; 30(6):700-703. PubMed ID: 32967985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in Manufacturer-Reported Nicotine Yields in Cigarettes Sold in the United States, 2013-2016.
    Kuiper N; Coats EM; Crawford TN; Gammon DG; Loomis B; Watson CH; Melstrom PC; Lavinghouze R; Rogers T; King BA
    Prev Chronic Dis; 2020 Nov; 17():E148. PubMed ID: 33241990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tobacco Retail Sales in Massachusetts and New Hampshire Before and After Massachusetts' Flavored Tobacco Restriction.
    McGinnes H; Kingsley M; Song G; Doane J; Henley P
    J Public Health Manag Pract; 2024 Jul-Aug 01; 30(4):512-516. PubMed ID: 38870369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis of cigarette sales during Poland's menthol cigarette sales ban: small effects with large policy implications.
    Liber AC; Stoklosa M; Levy DT; Sánchez-Romero LM; Cadham CJ; Pesko MF
    Eur J Public Health; 2022 Oct; 32(5):735-740. PubMed ID: 35679583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of pharmacy data to evaluate smoking regulations' impact on sales of nicotine replacement therapies in New York City.
    Metzger KB; Mostashari F; Kerker BD
    Am J Public Health; 2005 Jun; 95(6):1050-5. PubMed ID: 15914832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circumvention of COVID-19-related restrictions on tobacco sales by the e-cigarette industry in South Africa and comparative analyses of heated tobacco product vs combustible cigarette volume sales during 2018-2020.
    Agaku IT; Egbe CO; Ayo-Yusuf OA
    Prev Med; 2021 Jul; 148():106526. PubMed ID: 33745955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotine replacement therapy for smoking cessation.
    Silagy C; Mant D; Fowler G; Lancaster T
    Cochrane Database Syst Rev; 2000; (2):CD000146. PubMed ID: 10796494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of advertising on nicotine replacement therapy demand.
    Tauras JA; Chaloupka FJ; Emery S
    Soc Sci Med; 2005 May; 60(10):2351-8. PubMed ID: 15748682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Tobacco Smoking: A Review.
    Rigotti NA; Kruse GR; Livingstone-Banks J; Hartmann-Boyce J
    JAMA; 2022 Feb; 327(6):566-577. PubMed ID: 35133411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Pragmatic Randomized Comparative Trial of e-Cigarettes and Other Nicotine Products for Quitting or Long-Term Substitution in Smokers.
    Morphett K; Fraser D; Borland R; Hall W; Walker N; Bullen C; Gartner C
    Nicotine Tob Res; 2022 Jun; 24(7):1079-1088. PubMed ID: 34929031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotine replacement therapy for smoking cessation.
    Silagy C; Lancaster T; Stead L; Mant D; Fowler G
    Cochrane Database Syst Rev; 2001; (3):CD000146. PubMed ID: 11686953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cigarette consumption and sales of nicotine replacement products.
    Hu T; Sung HY; Keeler TE; Marciniak M
    Tob Control; 2000; 9 Suppl 2(Suppl 2):II60-3. PubMed ID: 10841593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between cigarette sales in the USA and FDA's announcement of its intention to prohibit menthol as a characterising flavour in cigarettes.
    Xue Z; Okitondo C; Asare S; Bandi P; Patel M; Nargis N
    Tob Control; 2023 Jul; ():. PubMed ID: 37487706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.